Frontiers in Cardiovascular Health
Over the past two decades, successful therapeutic cardiovascular disease strategies have focused primarily on lowering bad cholesterol (LDL) with statins, and reducing the risk of the blood clots that cause heart attacks or strokes with “blood thinners” such as aspirin. Blood pressure medications are also widely used. Despite these interventions, a significant number of patients experience recurrent events or disease progression.
